# Optura.ai

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/optura-ai

- Industry: Healthcare IT
- Headquarters: Nashville, US
- Website: www.optura.ai
- Total disclosed funding: $27M
- Latest round: Series A (Mar 23, 2026)
- Investors on record: 5

## About

Optura.ai is an innovative provider of artificial intelligence solutions tailored for the healthcare sector, focusing on streamlining operations and enhancing the efficacy of AI initiatives within organizations.Founded in 2024, Optura.ai specializes in developing AI solutions for the healthcare industry. The company successfully completed a Series A funding round on May 2026, Optura.ai raised USD 17.5 million in series A funding led by new investor Salesforce Ventures, with participation from another new investor Echo Health Ventures. Returning investors Susa Ventures, Matrix Partners, and HC9 Ventures also participated in the round. The founder's background in technology and healthcare allows for a deep understanding of industry challenges, though specific past ventures have not been disclosed. Optura specializes in healthcare AI solutions through its flagship product, the AI Enterprise Operating System (AIEOS). This platform is designed to streamline and orchestrate AI initiatives within healthcare organizations, enabling them to transition from fragmented pilot programs to comprehensive, enterprise-scale AI programs that yield measurable results. AIEOS integrates advanced AI capabilities to address challenges faced by healthcare payers, including operational inefficiencies, cost management, and the need for demonstrable return on investment (ROI). The platform is tailored for compliance with regulatory standards such as HIPAA and CMS, ensuring secure deployment across critical workflows. Optura serves a diverse client base that includes health plans, pharmacy benefit managers (PBMs), and healthcare technology vendors, primarily in the United States, but also targeting markets in Canada and Europe.Optura's revenue model is primarily built around a subscription-based structure for its AIEOS platform, which facilitates long-term partnerships with its healthcare clients. This model allows organizations to access the comprehensive suite of AI tools and services offered by Optura, with pricing typically structured around the scale and specific functionalities adopted by the client. Transactions generally occur through annual contracts, which include provisions for maintenance and support services, thereby ensuring client engagement and satisfaction. While specific pricing details are proprietary, the value proposition centers on delivering significant ROI through streamlined operations and cost savings. The company’s focus on measurable outcomes positions it as a critical partner for healthcare organizations looking to enhance their efficiency and competitiveness in the market. In May 2026, Optura.ai raised USD 17.5 million in series A funding led by new investor Salesforce Ventures, with participation from another new investor Echo Health Ventures. Returning investors Susa Ventures, Matrix Partners, and HC9 Ventures also participated in the round. The company will use the May 2026 funding  to expand its platform artificial intelligence capabilities, grow its platform development teams, and scale its large language model (LLM) partnerships.

## Funding rounds

- Series A, Mar 23, 2026, $21M — Matrix Partners, Susa Ventures, Salesforce Ventures, Echo Health Ventures, HC9 Ventures
- Seed, May 20, 2025, $6.5M — Matrix Partners, Susa Ventures

## Investors

- Matrix Partners (https://capitalatlas.ai/funds/matrix-partners) — Seed, Series A
- Susa Ventures (https://capitalatlas.ai/funds/susa-ventures) — Seed, Series A
- Salesforce Ventures (https://capitalatlas.ai/funds/salesforce-ventures) — Series A
- Echo Health Ventures (https://capitalatlas.ai/funds/echo-health-ventures) — Series A
- HC9 Ventures (https://capitalatlas.ai/funds/hc9-ventures) — Series A